RIMAN, a global leader in K-beauty and Direct Sales, recently announced that its proprietary Centella asiatica variety, Giant BYoungPool™, has been granted a 20-year Plant Variety Protection (PVP) by the United States Department of Agriculture (USDA).
This milestone secures RIMAN’s exclusive rights to cultivate and commercialize the variety, marking a significant step in the company’s growth trajectory in the United States.
The USDA approval formally acknowledges the distinctiveness and authenticity of Giant BYoungPool™, an advanced Centella cultivar developed by RIMAN through years of dedicated research.
With larger leaves and higher concentrations of active compounds than conventional Centella asiatica, Giant BYoungPool™ offers enhanced efficacy for skincare applications. Cultivated at RIMAN’s Smart Farm in Jeju Island, South Korea– the world’s first Smart Farm for Centella asiatica – the plants are grown under precision-controlled conditions to ensure consistent potency, premium quality, and sustainability.
“Beyond scientific validation, this recognition by the USDA affirms RIMAN’s commitment to brining trusted heritage ingredients to the global beauty industry,”
said Youngsu Hwang, Chief Sales Officer at RIMAN.
“This accomplishment strengthens our path to global expansion while staying true to our philosophy of innovation grounded in authenticity.”
Giant BYoungPool™ is the cornerstone ingredient of ICD—formally Incellderm—RIMAN’s flagship skincare brand. ICD has become one of the most celebrated names in K-beauty and is rapidly expanding into the United States and European markets.
By